title: FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma.
abstract: Adrenocortical carcinoma (ACC) is a rare tumor with aggressive behavior, high recurrence rate, and rapid evolution. Surgery is the only curative modality, while systemic treatments such as mitotane and chemotherapy associated to locoregional therapeutic tools remain as palliative options. Imaging has an important role in the management of patients with ACC both at diagnosis and during follow-up. First, it is necessary to characterize undetermined adrenal masses, selecting patients for surgery. Then, in case of malignancy, it is mandatory to assess disease extension, to detect early relapse during follow-up, and to evaluate treatment response. Computed tomography scan and magnetic resonance imaging are actually the most used techniques for these intents as they are widely available in clinical practice. (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) is routinely used for other malignancies and, on the basis of published data, is also becoming a promising tool in the management of ACC. Not only is it a diagnostic tool complementary to morphological imaging in the characterization of adrenal masses and in tumoral lesions detection, but it can be also useful to evaluate tumor response to treatment. New tracers and indications for the clinical use of FDG PET in this specific disease still have to be evaluated to assess its role in clinical practice.
authors.affiliation: Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, Villejuif, France. Desiree.DEANDREIS@igr.fr
authors.forename: Désirée
authors.initials: D
authors.lastname: Deandreis
authors.forename: Sophie
authors.initials: S
authors.lastname: Leboulleux
authors.forename: Caroline
authors.initials: C
authors.lastname: Caramella
authors.forename: Martin
authors.initials: M
authors.lastname: Schlumberger
authors.forename: Eric
authors.initials: E
authors.lastname: Baudin
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000503:physiopathology; D000311:Adrenal Glands / Q000000981:diagnostic imaging* / Q000473:pathology; D018268:Adrenocortical Carcinoma / Q000000981:diagnostic imaging* / Q000473:pathology / Q000503:physiopathology; D000818:Animals; D018450:Disease Progression; D019788:Fluorodeoxyglucose F18; D006801:Humans; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
references.citation: J Nucl Med. 2001 Dec;42(12):1795-9
references.pmid: 11752075
references.citation: Eur J Radiol. 2009 Feb;69(2):314-23
references.pmid: 18082990
references.citation: Ann Endocrinol (Paris). 2010 Sep;71 Suppl 1:S1-2
references.pmid: 21237325
references.citation: J Clin Oncol. 2007 Aug 20;25(24):3746-52
references.pmid: 17646666
references.citation: Am J Surg Pathol. 1989 Mar;13(3):202-6
references.pmid: 2919718
references.citation: J Nucl Med. 2001 Jun;42(6):884-92
references.pmid: 11390552
references.citation: J Clin Endocrinol Metab. 2006 Jul;91(7):2665-71
references.pmid: 16621901
references.citation: J Clin Endocrinol Metab. 2006 Apr;91(4):1410-4
references.pmid: 16403816
references.citation: AJR Am J Roentgenol. 2008 May;190(5):1163-8
references.pmid: 18430826
references.citation: Ann Surg Oncol. 1999 Dec;6(8):719-26
references.pmid: 10622498
references.citation: Eur J Endocrinol. 2000 Jul;143(1):111-7
references.pmid: 10870039
references.citation: Radiology. 2011 Jan;258(1):270-6
references.pmid: 21045185
references.citation: Radiology. 2006 Feb;238(2):578-85
references.pmid: 16371582
references.citation: Eur J Cancer. 2009 Jan;45(2):228-47
references.pmid: 19097774
references.citation: J Nucl Med. 2003 Sep;44(9):1407-12
references.pmid: 12960184
references.citation: Radiology. 2006 Mar;238(3):970-7
references.pmid: 16505394
references.citation: J Vasc Interv Radiol. 2010 Oct;21(10):1527-32
references.pmid: 20801688
references.citation: J Endocrinol Invest. 2006 Apr;29(4):298-302
references.pmid: 16699294
references.citation: Eur J Cancer. 1999 Dec;35(13):1773-82
references.pmid: 10673991
references.citation: Cancer. 1981 Jan 1;47(1):207-14
references.pmid: 7459811
references.citation: AJR Am J Roentgenol. 1998 Jul;171(1):201-4
references.pmid: 9648789
references.citation: Abdom Imaging. 2008 Jan-Feb;33(1):87-93
references.pmid: 17632751
references.citation: J Nucl Med. 2010 Dec;51(12):1833-40
references.pmid: 21078787
references.citation: N Engl J Med. 1990 Apr 26;322(17):1195-201
references.pmid: 2325710
references.citation: J Nucl Med. 1994 Dec;35(12):1965-9
references.pmid: 7989978
references.citation: AJR Am J Roentgenol. 2004 Jul;183(1):215-9
references.pmid: 15208141
references.citation: Radiology. 2011 Apr;259(1):117-26
references.pmid: 21330566
references.citation: Pediatr Radiol. 2000 May;30(5):306
references.pmid: 10836591
references.citation: Eur J Nucl Med Mol Imaging. 2004 Sep;31(9):1224-30
references.pmid: 15197504
references.citation: Radiology. 2000 Dec;217(3):798-802
references.pmid: 11110946
references.citation: Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):403-10
references.pmid: 12634969
references.citation: J Clin Endocrinol Metab. 2009 Dec;94(12):4757-67
references.pmid: 19864450
references.citation: Arch Surg. 1999 Feb;134(2):181-5
references.pmid: 10025460
references.citation: Radiology. 1996 Sep;200(3):743-7
references.pmid: 8756925
references.citation: Eur J Nucl Med Mol Imaging. 2004 Oct;31(10):1413-20
references.pmid: 15205922
references.citation: AJR Am J Roentgenol. 2008 Nov;191(5):1545-51
references.pmid: 18941099
references.citation: Radiology. 2004 Jun;231(3):711-6
references.pmid: 15118113
references.citation: Exp Clin Endocrinol Diabetes. 2009 Jul;117(7):316-9
references.pmid: 19053031
references.citation: Am J Surg Pathol. 1984 Mar;8(3):163-9
references.pmid: 6703192
references.citation: Cancer. 2001 Sep 15;92(6):1385-92
references.pmid: 11745214
references.citation: Cancer. 2003 Feb 1;97(3):554-60
references.pmid: 12548596
references.citation: World J Surg. 2001 Jul;25(7):891-7
references.pmid: 11572030
references.citation: Cancer. 1996 Nov 15;78(10):2216-22
references.pmid: 8918417
references.citation: J Nucl Med. 2009 May;50 Suppl 1:122S-50S
references.pmid: 19403881
references.citation: J Clin Oncol. 2007 May 1;25(13):1753-9
references.pmid: 17470865
references.citation: Endocr Relat Cancer. 2009 Sep;16(3):907-18
references.pmid: 19240185
references.citation: Radiology. 2002 Mar;222(3):629-33
references.pmid: 11867777
references.citation: Eur J Endocrinol. 2011 Jun;164(6):851-70
references.pmid: 21471169
references.citation: Eur J Endocrinol. 2004 Jun;150(6):789-92
references.pmid: 15191348
references.citation: Radiology. 2010 Aug;256(2):504-10
references.pmid: 20656838
references.citation: Cancer. 2009 Jan 15;115(2):243-50
references.pmid: 19025987
references.citation: N Engl J Med. 2007 Feb 8;356(6):601-10
references.pmid: 17287480
references.citation: J Clin Oncol. 2002 Feb 15;20(4):941-50
references.pmid: 11844815
references.citation: Radiology. 2010 Dec;257(3):674-84
references.pmid: 20829538
references.citation: Endocrinol Metab Clin North Am. 2000 Mar;29(1):159-85, x
references.pmid: 10732270
references.citation: J Clin Endocrinol Metab. 2011 Mar;96(3):665-71
references.pmid: 21193541
references.citation: Endocr Relat Cancer. 2010 Aug 16;17(3):797-807
references.pmid: 20592067
references.citation: Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1669-78
references.pmid: 20490488
references.citation: Eur J Endocrinol. 2011 Jan;164(1):89-94
references.pmid: 20921280
references.citation: Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1316-22
references.pmid: 18338164
references.citation: AJR Am J Roentgenol. 1998 Mar;170(3):747-52
references.pmid: 9490968
references.citation: Br J Cancer. 2003 Sep 1;89(5):870-6
references.pmid: 12942120
references.citation: Clin Nucl Med. 2003 Jun;28(6):494-7
references.pmid: 12917534
references.citation: Endocr Relat Cancer. 2009 Sep;16(3):919-28
references.pmid: 19465749
references.citation: Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):29-35
references.pmid: 16193311
references.citation: Br J Cancer. 1994 May;69(5):947-51
references.pmid: 8180029
references.citation: J Clin Endocrinol Metab. 1999 Jul;84(7):2291-302
references.pmid: 10404792
references.citation: Cancer. 2001 Sep 1;92(5):1144-50
references.pmid: 11571727
references.citation: J Clin Endocrinol Metab. 2006 Mar;91(3):920-5
references.pmid: 16368753
references.citation: J Nucl Med. 2000 Feb;41(2):275-82
references.pmid: 10688111
references.citation: AJR Am J Roentgenol. 2009 Apr;192(4):956-62
references.pmid: 19304700
references.citation: Cancer Biother Radiopharm. 2001 Aug;16(4):289-95
references.pmid: 11602999
references.citation: Acad Radiol. 2007 Apr;14(4):468-75
references.pmid: 17368217
references.citation: J Clin Endocrinol Metab. 2007 Jan;92(1):148-54
references.pmid: 17062775
references.citation: J Clin Endocrinol Metab. 2009 May;94(5):1713-22
references.pmid: 19190108
references.citation: Oncol Rep. 2008 Dec;20(6):1381-5
references.pmid: 19020718
references.citation: J Nucl Med. 2006 Jan;47(1):32-7
references.pmid: 16391184
references.citation: Eur J Nucl Med Mol Imaging. 2008 Nov;35(11):2018-25
references.pmid: 18566816
references.citation: Endocr Relat Cancer. 2005 Sep;12(3):657-66
references.pmid: 16172198
references.citation: Radiology. 2006 Aug;240(2):587-96
references.pmid: 16864679
references.citation: Int J Clin Pract. 2007 May;61(5):802-9
references.pmid: 17343665
references.citation: J Clin Oncol. 1993 Jan;11(1):161-5
references.pmid: 8418229